pharmacological reports سال:2016 - دوره:68

Fa | Ar | En


pharmacological reports
سال:2016 - دوره:68 - شماره:4

A study of chemokines,chemokine receptors and interleukin-6 in patients with panic disorder,personality disorders and their co-morbidity - صفحه:756-763 Allopurinol decreases serum uric acid level and intestinal glucose transporter-5 expression in rats with fructose-induced hyperuricemia - صفحه:782-786 Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence - صفحه:827-836 Circadian rhythm abnormalities - Association with the course of inflammatory bowel disease - صفحه:847-851 Circulatory effect of TCS-80,a new imidazoline compound,in rats - صفحه:715-719 Common links between metabolic syndrome and inflammatory bowel disease: Current overview and future perspectives - صفحه:837-846 Current and future trends in the lipid lowering therapy - صفحه:737-747 Effect of trans-chalcone on atheroma plaque formation,liver fibrosis and adiponectin gene expression in cholesterol-fed NMRI mice - صفحه:720-727 Food,nutrients and nutraceuticals affecting the course of inflammatory bowel disease - صفحه:816-826 Imidazoacridinone antitumor agent C-1311 as a selective mechanism-based inactivator of human cytochrome P450 1A2 and 3A4 isoenzymes - صفحه:663-670 Inflammatory bowel disease treatment - صفحه:787-788 Inflammatory bowel diseases and reproductive health - صفحه:859-864 Influence of caffeine on the protective activity of gabapentin and topiramate in a mouse model of generalized tonic-clonic seizures - صفحه:680-685 Is insulin-like growth factor 1 (IGF-1) system an attractive target inflammatory bowel diseases? Benefits and limitation of potential therapy - صفحه:809-815 Janus kinases in inflammatory bowel disease: Four kinases for multiple purposes - صفحه:789-796 L-NAME differential effects on diazepam and flunitrazepam responses of rats in the object recognition test - صفحه:728-732 LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity - صفحه:802-808 Lurasidone: The 2016 update on the pharmacology,efficacy and safety profile - صفحه:748-755 Narrow time window of metabolic changes associated with transition to overt heart failure in Tgaq∗44 mice - صفحه:707-714 Natural terpenoids as a promising source for modulation of GABAergic system and treatment of neurological diseases - صفحه:671-679 Opioid-induced redistribution of 6TM and 7TM mu opioid receptors: A hypothesized mechanistic facilitator model of opioid-induced hyperalgesia - صفحه:686-691 Peroxisome proliferator-activated receptor-α stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle - صفحه:692-702 Pharmacokinetics of paracetamol in patients with chronic pancreatitis - صفحه:733-736 Pharmacology and metabolism of infliximab biosimilars - A new treatment option in inflammatory bowel diseases - صفحه:797-801 Pharmacotherapy in detrusor underactivity: A new challenge for urologists and pharmacologists (from lab to clinic) - صفحه:703-706 Possible neuroprotective mechanisms of clove oil against icv-colchicine induced cognitive dysfunction - صفحه:764-772 The influence of family pattern abnormalities in the early stages of life on the course of inflammatory bowel diseases - صفحه:852-858 Transdermal immunotherapy: Past,present and future - صفحه:773-781